Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy

Condition:   Head and Neck Cancer
Intervention:   Drug: Nivolumab
Sponsors:   Sulsau-Ul Haque;   Bristol-Myers Squibb
Not yet recruiting

http://ift.tt/2AeyZT5